Detail publikace

Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

CHAROUSOVÁ, M. DOSTÁLOVÁ, S. HEGER, Z. ADAM, V.

Originální název

Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

Typ

článek ve sborníku ve WoS nebo Scopus

Jazyk

angličtina

Originální abstrakt

Small interfering RNA also known as siRNA are a short 21-23 base-pair RNA duplexes. Its leading strand is complementary to a sequence of mRNA. Interaction between mRNA and siRNA leads sequence-specific gene expression suppression, also known as RNA interference (RNAi). RNAi was first discovered in plants and later was demonstrated in Caenorhabditis elegans. Now it is known, that this mechanism can be naturally found also in mammalian cells.

Klíčová slova

siRNA; Apoferritin; Cancer Cells

Autoři

CHAROUSOVÁ, M.; DOSTÁLOVÁ, S.; HEGER, Z.; ADAM, V.

Vydáno

5. 9. 2018

ISSN

2296-9667

Periodikum

European & Global Summit for Clinical Nanomedicine and Targeted Medicine

Stát

Švýcarská konfederace

Strany od

173

Strany do

174

Strany počet

2

BibTex

@inproceedings{BUT151237,
  author="Markéta {Charousová} and Simona {Dostálová} and Zbyněk {Heger} and Vojtěch {Adam}",
  title="Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells",
  booktitle="CLINAM 2018",
  year="2018",
  journal="European & Global Summit for Clinical Nanomedicine and Targeted Medicine",
  pages="173--174",
  issn="2296-9667"
}